In The News
Revolutionizing ICU Care: Advancing nutritional technology through clinical trials | Interview with Liron Elia
“We found by optimizing nutrition and its delivery, we were able to reduce patients’ length of stay in the ICU and their length of ventilation by more than three days. This outcome is truly remarkable. For the first time ever, our study establishes a direct correlation between the way people receive nutrition in the ICU and the length of time they spend there.”
Medical Device & Technology, August 17, 2023
Robot-guided nutrition management platform improves feeding efficacy in ICU patients
Compared with manual care for enterally fed ICU patients, a nutrition management platform guided by a robot met feeding goals more frequently and shortened stay and ventilation duration, according to results published in Clinical Nutrition.
Healio, August 10, 2023
Revolutionary critical care technology reduces length of stay and ventilation in ICU
A comparative randomized study evaluating the performance of the smART+ Platform has shown that it can maximize feeding efficiency, achieving nearly 90% of the targeted nutrition goal, and enhance patient outcomes by reducing both the ICU length of stay and the length of ventilation by 3.3 days. This significant advancement paves the way for the commercialization of ART MEDICAL’s revolutionary technology.
HospiMedica, July 26, 2023
New clinical study shows unprecedented results of ART MEDICAL's smART+ Platform
ART MEDICAL, an Israeli medical device company committed to its vision of detecting and preventing intensive care unit (ICU)-acquired complications such as aspiration pneumonia, malnutrition and acute kidney injury, unveiled unprecedented results on the performance of its smART+ Platform in a randomized comparative study published by the European Society for Clinical Nutrition and Metabolism’s (ESPEN’s) Clinical Nutrition.
Cision, July 24, 2023
ART MEDICAL announces partnership with Teva Israel to bring its lifesaving technology to critical care units
ART MEDICAL Ltd. is pleased to announce its collaboration with Teva Israel. Under the terms of the agreement, Teva Israel will market and distribute ART MEDICAL’s ground-breaking smART+ Platform in Israel’s intensive care units. The smART+ Platform is a robotic-assisted technology that aims to reduce complications related to feeding tube malposition, malnutrition, VAP, and AKI.
Accesswire, March 16, 2023
At Rabin medical center, the intensive care department uses a breakthrough technology to treat patients
In Beilinson Hospital, intensive care patients are now being treated using breakthrough technology – therapeutic medical devices for optimal nutrition and malnutrition prevention. It is the first department in the world to implement this advanced technology through ART MEDICAL’s smART+ platform.
Clalit, October 12, 2021
ART MEDICAL creates life-saving algorithms for its sensor-based smart tubes platform
ART MEDICAL’s sensor-based platform collects new, and untapped patient data to reduce the risks of medical complications. ART MEDICAL is the first to develop advanced algorithms that automate the placement of feeding tubes, and detection of gastric content aspiration to improve clinical outcomes.
Dotmed, February 20, 2018
This Israeli startup brings sensor-based smart tubes to the ICU
ART MEDICAL, a company based in Israel and Palo Alto, has products that seek to prevent complications that can arise from intubation, including aspiration pneumonia, VAP, and acute kidney injury. Such Complications can lengthen a patient’s stay in the hospital and increase their mortality risk.
Medcity, February 23, 2018
Israeli MedTech company wants to stop hospitals from making you sicker
This company’s wide array of sensors and smart devices can warn what needs to be done to avoid fatal situations and sometimes automate them altogether. ART MEDICAL claims that this platform will save lives, as fewer people will be afflicted by hospital-acquired pneumonia.
Techworm, September 17, 2020
ART MEDICAL’s technology to prevent pneumonia in ICU: Interview with CEO Liron Elia
Pneumonia arising from the use of ventilators and feeding tubes in the ICU is disturbingly common and often life-threatening. ART MEDICAL, a company based in Netanya, Israel, has developed technology that may help prevent aspiration pneumonia and ventilator-associated pneumonia.
Medgadget, July 31, 2017
ART MEDICAL seeks to make hospitals safer
ART MEDICAL has developed a solution designed to reduce mortality among patients on respirators and fed through tubes: “When we show hospitals that we are lowering hospitalization costs, and even saving an average of one day of hospitalization in intensive care, the price of the system will no longer be an issue.”
Globes, June 08, 2017
ART MEDICAL raises $20 million for its smart feeding tubes
The Israeli company is creating an intelligent feeding tube platform with integrated sensors and a monitoring system, enabling real-time responses to prevent medical complications.
Geektime, June 08, 2017